Dr Samanta Mariani in lab

11 Aug 2021 Research

Dr Samanta Mariani recognised for her innovative research through Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award

Dr Samanta MarianiWe are delighted to announce the Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award. This new award will be conferred each year to one awardee of a Leukaemia UK John Goldman Fellowship for Future Science. This accolade combined with the John Goldman Fellowship is in recognition of an innovative higher-risk idea that could contribute significantly to our understanding of leukaemia and other blood cancers.

The 2021 Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award is awarded to Dr Samanta Mariani (University of Edinburgh). Samanta is one of Leukaemia UK’s 2021 John Goldman Fellows.

Samanta’s innovative research focuses on infant leukaemia, the most common type of cancer in children and often difficult to treat. Her novel work will investigate the role of leukaemia associated macrophages in the onset and progression of MLL-AF9 infant leukaemia. It is hoped that a better understanding of what happens at the very early stages of leukaemia development could lead to the discovery of new therapeutic strategies for treating infants with leukaemia.

Olive was CEO of Leukaemia UK (formerly known as Leuka) from 2011-2020. She worked with Leuka’s founder, the late Prof Goldman, sharing his ethos to support innovative, pioneering research. To that end, after his death, in 2014 Olive created The John Goldman Fellowship for Future Science programme to fund the brightest scientific minds. The programme has since gained worthy recognition, having supported over 30 top researchers though critical stages of their careers.

Olive Boles said,“It is a pleasure to be associated with the John Goldman Fellowships programme that owes its success to many. Thanks to John for his exemplary inspiration. To his Fellows, like Samanta, whose brilliant minds never cease to amaze us. Their innovative ideas literally have the power to change lives. And to the charity’s donors, scientific advisors and staff, whose efforts and generosity keep the programme going.”
“It is a real honour to be awarded the Leukaemia UK John Goldman Fellowship and Olive Boles Innovation Award. Thanks to Leukaemia UK for this amazing recognition and for believing in my research project on infant leukaemia. To Olive Boles for being a true inspiration and for her pivotal role in creating the JG Fellowship scheme. A huge thanks to the charity’s donors whose generosity keeps scientific research going. Together we can beat infant leukaemia.” – Dr Samanta Mariani

Olive was previously Chief Health Advisor and Director at the International Business Leaders Forum, where she led a Global Nutrition Initiative. Olive has held senior positions within the UK’s National Health Service, including Regional Director of Health Education and Executive Director of a Primary Health Care Trust.

Olive has also worked with Governments and Multilateral Organisations on many national and international health campaigns, including HIV/AIDS, heart disease prevention, and maternal and child health. Olive began her career as a social scientist and is a graduate of Cambridge University’s Programme for Industry.

Related posts

New campaign launches for the forgotten 500,000 families

17 October 2022

New campaign launches for the forgotten 500,000 families

Patient groups, charities and clinicians unite to raise awareness of half a million vulnerable people, many of whose lives have never returned to normal after the Covid-19 lockdown. A new…

Together we are changing lives – Here’s how your support is making it happen

3 July 2025

Together we are changing lives – Here’s how your support is making it happen

At this point in our advocacy journey, we wanted to share an update to you, our supporters, on everything we’ve achieved so far and what’s next as we continue to…

Family ‘devastated’ by leukaemia after double diagnosis say ‘so much more needs to be done’

8 December 2023

Family ‘devastated’ by leukaemia after double diagnosis say ‘so much more needs to be done’

57-year-old Hampshire resident Karen Cracknell is supporting Leukaemia UK’s appeal for funds this Christmas, having experienced the ‘devastating impact’ after both her mother and father were diagnosed with blood cancer.  …

Trailblazing research project announced to exploit novel weaknesses in one of the least survivable cancers

21 April 2023

Trailblazing research project announced to exploit novel weaknesses in one of the least survivable cancers

A pioneering new study hopes to accelerate progress towards a new treatment for acute myeloid leukaemia (AML) in research announced today on World AML Day by Leukaemia UK.   University of…